Abstract Background Systemic reactivation of Epstein–Barr virus (EBV) may occur in novel
coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory syndrome …

The absence of any formally licensed antiadenovirus drugs and the increasing incidence of
life-threatening adenovirus infections in immunosuppressed patients warrant the …

ABSTRACT 2, 5, 6-Trichloro-1-β-d-ribofuranosyl benzimidazole (TCRB) is a potent and
selective inhibitor of human cytomegalovirus (HCMV) replication. TCRB acts via a novel …

Ganciclovir is a nucleoside guanosine analogue which incorporates ganciclovir
triphosphate (the active moiety) into DNA during elongation, thereby inhibiting viral …

To meet product quality and cost parameters for therapeutic monoclonal antibody (mAb)
production, cell lines are required to have excellent growth, stability, and productivity …

Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), varicella-zoster virus (VZV),
cytomegalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), and …

Clinical Aspects and Management of Cytomegalovirus Infection Page 1 Journal of Infection (2002)
44: 78ą83 doi:10.1053/jinf.2001.0949, available online at http://www.idealibrary.com on …

Antiviral therapy for cytomegalovirus (CMV) plays an important role in the clinical
management of solid organ and hematopoietic stem cell transplant recipients. However …

Little is known regarding anterior uveitis (AU), the most common ocular disease associated
with cytomegalovirus (CMV) infection in immunocompetent populations. CMV AU is highly …

There is convincing evidence that Epstein–Barr virus (EBV) is associated with post‐
transplant lymphoproliferative disease (PTLD). Primary EBV infection following …